Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury

Journal of Neurotrauma

Volumn 13, Issue 5, 1996, Pages 267-272

  Ibarra, Antonio ^a   Guízar Sahagún, Gabriel ^a   Correa, Dolores ^b   Kretschmer, Roberto ^a   Grijalva, Israel ^a   Flores Murrieta, Francisco J ^c   Castañeda Hernández, Gilberto ^c   Odor, Alberto ^d   López, Rosa M ^d   Franco Bourland, Rebecca ^a,d   Espitia, Ana L ^a   Salgado Ceballos, Hermelinda ^a   Madrazo, Ignacio ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

bioavailability; cyclosporin A; immunosuppressive agents; neural transplantation; paraplegia; pharmacokinetics; spinal cord injury

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; FEMALE; GASTROINTESTINAL ABSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LAMINECTOMY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPINAL CORD INJURY;

EID: 15844395462     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.267     Document Type: Article

References (24)

1. ALLEN, A. (1911). Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. J. Am. Med. Assoc. 57, 878-880.
2. ANDERSON, D.K., REIER, P.J., WIRTH, E.D., THEELE, D.P., MARECI, T., and BROWN, S.A. (1991). Delayed grafting of fetal CNS tissue into chronic compression lesions of the adult cat spinal cord. Rest. Neurol. Neurosci. 2, 309-325.
3. BOREL, J. (1991). Mechanism of action of cyclosporin-A and rationale for its use in nephrotic syndrome. Clin. Nephrol. 35, 23-30.
4. BRUNDIN, P., WIDNER, H., NILSSON, O., STREECKER, R., and BJORKLUND, A. (1989). Intracerebral xenografts of dopamine neurons: Role of immunosuppression and blood-brain barrier. Exp. Brain Res. 75, 195-207.
5. CLAUS-WALKER, J., and DUNN, C.D. (1984). Spinal cord injury and serum erythropoietin. Arch. Phys, Med. Rehabil. 65, 370-374.
6. COHEN, D., LOERTSCHER, R., RUBIN, M., TILNEY, N., CARPENTER, C., and STORM, T. (1984). Cyclosporin: A new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 101, 667.
7. FINSEN, B., POULSEN, P.H., and ZIMMER. J. (1988). Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: Effect of cyclosporin A treatment. Exp. Brain Res. 70, 117-133.
8. GUÍZAR-SAHAGÚN, G., GRIJALBA, I., MADRAZO, I., et al. (1994a). Development of post-traumatic cysts in the spinal cord of rats subjected to severe spinal cord contusion. Surg. Neurol. 41, 241-249.
9. GUÍZAR-SAHAGÚN, G., GRIJALVA, I., MADRAZO, I., et al. (1994b). Neuroprotection of completely lacerated spinal cord of adult rats by homotopic and heterotopic transplantation. Rest. Neurol. Neurosci. 7, 61-70.
10. HALSTEAD, L.S., FELDMAN, S., CLAUS-WALKER, J., and PATEL, V.C. (1985). Drug absorption in spinal cord injury. Arch. Phys. Med. Rehabil. 66, 298-301.
11. JOHANSSON, B., and LANGSTON, J.B. (1964). Reflex influence of mesenteric afferents on renal, intestinal and muscle blood flow on intestinal motility. Acta Physiol. Scand. 61, 400-412.
12. KAHAN, B.D. (1989). Cyclosporin. N. Engl. J. Med. 321, 1725-1738.
13. KRASSIOUKOV, A.V., and WEAVER, L.C. (1995). Episodic hypertension due to autonomic dysreflexia in acute and chronic spinal cord-injured rats. Am. J. Physiol. 268, H2077-H2083.
14. LENSMEYER, G.L., WIEBE, D.A., and CARLSON, I.H. (1989). Distribution of cyclosporin A metabolites among plasma and cells in whole blood: Effect of temperature, hematocrit and metabolite concentration. Clin. Chem. 35, 56-63.
15. MIZRACHI, Y., OHRY, A., AVIAL, A., ROZIN, R., BROOKS, E., and SCHWARTZ, M. (1983). Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 22, 287-293.
16. PALLADINI, G., GRISSI, M., MALECI, A., and LAURO, M. (1987). Immunocomplexes in the rat and rabbit spinal cord after injury. Exp. Neurol. 95, 639-651.
17. ROCCI, M.L., and JUSKO, W.J. (1983). LAGRAN program for area and moments in pharmacokinetic analysis. Comput. Programs Biomed. 16, 203-216.
18. ROWLAND, M., and TOZER, T.N. (1989). Clinical Pharmacokinetics Concepts and Applications. Lea & Febiger: Philadelphia, pp. 149-176.
19. SEGAL, J.L., BRUNNEMANN, S., GORDON, S., and ELTORAI, I.M. (1985). Decreased theophylline bioavailability and impaired gastric emptying in spinal cord injury. Curr. Ther. Res. 38, 831-846.
20. SEGAL, J.L., BRUNNEMANN, S., GRAY, D., GORDON, S., and ELTORAI, I.M. (1986). Impaired absorption of intramuscularly administered gentamicin in spinal cord injury. Curr. Ther. Res. 39, 961-969.
21. SEGAL, J.L., MILNE, N., BRUNNEMANN, S.R., and LYONS, K.P. (1987). Metoclopramide-induced normalization of impaired gastric emptying in spinal cord injury. Am. J. Gastroenterol. 82, 1143-1148.
22. SEGAL, J.L., BRUNNEMANN, S.R., ELTORAI, I.M,. and VULPE, M. (1991). Decreased sytemic clearance of lorazepam in humans with spinal cord injury. J. Clin. Pharmacol. 31, 651-656.
23. STEEL, R.G., and TORRIE, J.H. (1960). Principles and Procedures of Statistics with Special References to the Biological Sciences. McGraw Hill: New York, pp. 110-120.
24. WRATHALL, J.R. (1992). Spinal cord injury models. J. Neurotrauma 9(Suppl. 1), S129-S134.